Back to results
US 2026/0265777 A1Published application
Expression construct
AssigneeLentitek Ltd
InventorsAdam Inche, Leif Anderson
Life of this patent
Estimating the term…
Abstract
The disclosure relates to constructs, especially lentivral constructs for use in an expression system for cell and/or gene therapy applications. The constructs include a viral genome, the expression of which is controlled by an RNA polymerase I promoter.
Claims31
A lentiviral genome construct comprising a lentiviral genome and a RNA polymerase I promoter, wherein expression of the lentiviral genome is under control of the RNA Polymerase I promoter.
A construct for use in an expression system, wherein the construct comprises:
- an insert flanked by a 5′ long terminal repeat (5′ LTR) and a 3′ long terminal repeat (3′ LTR), wherein the 5′ LTR is downstream of an RNA polymerase I (Pol I) promoter and the 3′ LTR is upstream of a Pol I termination signal, wherein said insert comprises a transgene and wherein the 5′ LTR and/or 3′ LTR may be self-inactivating.
23-32. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.